Diko : en:documentation that the patient is not on daily aspirin or anti-platelet regimen

en:documentation that the patient is not on daily aspirin or anti-platelet regimen

Catégories

Nom

Informations lexicales

Langue:anglais

Informations sémantiques

source:wiki

Liens externes

›

umls:C3710382

Associations d'idées

[F]

›

364

en:documentation of active injection drug use

•

en:voice functional limitation, current status at therapy episode outset and at reporting intervals

•

en:antibiotic regimen prescribed within 10 days after onset of symptoms for documented medical reason

•

en:patients with cardiac tamponade and/or pericardiocentesis occurring within 30 days

•

en:voice functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:one high-risk medication not ordered

•

en:aspirin not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)

•

en:final reports for abdominal imaging studies with follow-up imaging recommended

•

en:major amputation or open surgical bypass required within 48 hours of the index endovascular lower extremity revascularization procedure

•

en:patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soaap-r) or patient interviewed at least once during opioid therapy

•

en:patient underwent abdominal imaging with ultrasound, contrast enhanced ct or contrast mri for hcc

•

en:patients prescribed opiates for longer than six weeks

•

en:patients with 90 day mrs score greater than 2

•

en:documentation of patient without one or more complications and without mortality within 30 days

•

en:specimen site other than anatomic location of lung or is not classified as primary non-small cell lung cancer

•

en:patient treated with a beta-lactam antibiotic as definitive therapy

•

en:other speech language pathology functional limitation, current status at therapy episode outset and at reporting intervals

•

en:documentation of patient reason(s) for not receiving annual screening for hcv infection (e.g., patient declined, other patient reasons)

•

en:statin prescribed at discharge

•

en:patient offered assistance with end of life issues during the measurement period

•

en:pathology report does not include the pt category and a statement on thickness and ulceration and for pt1, mitotic rate

•

en:patient with an initial phq-9 score greater than nine who did not achieve remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score greater than or equal to five

•

en:patients who are currently statin therapy users or received an order (prescription) for statin therapy

•

en:major amputation or open surgical bypass not required within 48 hours of the index endovascular lower extremity revascularization procedure

•

en:imaging study not named according to standardized nomenclature, reason not given

•

en:patient not evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soaap-r) or patient not interviewed at least once during opioid therapy

•

en:individual did not have a pdc of 0.8 or greater

•

en:operative report identifies the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant

•

en:no unplanned rupture of the posterior capsule requiring vitrectomy during cataract surgery

•

en:national committee for quality assurance - level 1 medical home

•

en:motor speech functional limitation, discharge status, at discharge from therapy or to end reporting

•

en:intent for potential removal at time of placement

•

en:dsm-iv-tr criteria for major depressive disorder not documented at the initial evaluation, reason not otherwise specified

•

en:documented reason for not assessing hepatitis b virus (hbv) status (e.g. patient not receiving a first course of anti-tnf therapy, patient declined) within one year prior to first course of anti-tnf therapy

•

en:documentation of system reason(s) for ordering an advanced brain imaging study (i.e., needed as part of a clinical trial; other clinician ordered the study)

•

en:all quality actions for the applicable measures in the optimizing patient exposure to ionizing radiation measures group have been performed for this patient

•

en:all quality actions for the applicable measures in the general surgery measures group have been performed for this patient

•

en:patient did not sustained bladder injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:patient did not require a return to the operating room within 90 days of surgery

•

en:documentation of system reason(s) for not prescribing beta-blocker therapy (eg, other reasons attributable to the health care system)

•

en:patient discharge to home no later than post-operative day #7

•

en:intervention for presence of leak of endoluminal contents through an anastomosis not required

•

en:patient sustained bladder injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:remission at twelve months as demonstrated by a twelve month (+/-30 days) phq-9 score of less than 5

•

en:patient survey score improved from baseline following treatment

•

en:patients who are evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g. history of dvt, pe, mi, arrhythmia and stroke)

•

en:memory functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:mapcp demonstration - community health teams

•

en:rna testing for hepatitis c documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c

•

en:hepatitis c quantitative rna testing documented as performed between 4-12 weeks after the initiation of antiviral treatment

•

en:dsm-ivtm criteria for major depressive disorder documented at the initial evaluation

•

en:antiretroviral therapy prescribed

•

en:antibiotic regimen not prescribed within 10 days after onset of symptoms

•

en:symptomatic aaas that required urgent/emergent (non-elective) repair

•

en:final reports for abdominal imaging studies with follow-up imaging not recommended

•

en:post-partum screenings, evaluations and education not performed

•

en:all quality actions for the applicable measures in the multiple chronic conditions measures group have been performed for this patient

•

en:transfer of care during an anesthetic or to the intensive care unit

•

en:statin not prescribed at discharge

•

en:services performed by dietary counselor in the hospice setting, each 15 minutes

•

en:services performed by care coordinator in the hospice setting, each 15 minutes

•

en:primary non-small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation

•

en:patient sustained ureter injury at the time of surgery or discovered subsequently up to 1 month post-surgery

•

en:photodocumentation of one or more cecal landmarks to establish a complete examination

•

en:pcp prophylaxis was not prescribed within 3 months of low cd4+ cell count below 200 cells/mm3, reason not given

•

en:patient not screened for uterine malignancy, or those that have not had an ultrasound and/or endometrial sampling of any kind, reason not given

•

en:patients with clinical ascvd diagnosis

•

en:memory functional limitation, discharge status at discharge from therapy or to end reporting

•

en:mapcp demonstration - physician incentive pool

•

en:antibiotic regimen prescribed within10 days after onset of symptoms

•

en:all quality actions for the applicable measures in the sinusitis measures group have been performed for this patient

•

en:antiretroviral thereapy not prescribed

•

en:aortic aneurysm 6.0 cm or greater maximum diameter on centerline formatted ct or minor diameter on axial formatted ct

•

en:pneumocystis jiroveci pneumonia prophylaxis prescribed wthin 3 months of low cd4+ cell count below 200 cells/mm3

•

en:warfarin responsiveness testing by genetic technique using any method, any number of specimen(s)

•

en:unplanned hospital readmission within 30 days of principal procedure

•

en:spoken language comprehension functional limitation, discharge status, at discharge from therapy or to end reporting

•

en:clinician documented reason patient was not able to complete 30 day follow-up from acute inpatient setting discharge (e.g., patient death prior to follow-up visit, patient non-compliant for visit follow-up)

•

en:specimen site other than anatomic cutaneous location

•

en:seen pre-operatively by anesthesiologist or proxy prior to the day of surgery

•

en:specimen site other than anatomic location of lung or classified as nsclc-nos

•

en:patients with 90 day mrs score of 0 to 2

•

en:documentation of planned hybrid or staged procedure

•

en:documentation of patient death following cea

•

en:documentation of medical reason for not performing foot exam (i.e., patients who have had either a bilateral amputation above or below the knee, or both a left and right amputation above or below the knee before or during the measurement period)

•

en:documentation of at least two attempts to reach the patient to arrange a clinical re-assessment for the appropriateness of filter removal within 3 months of placement

•

en:count of previous ct and cardiac nuclear medicine (myocardial perfusion) studies not documented in the 12-month period prior to the current study, reason not given

•

en:p2y inhibitor not prescribed at discharge

•

en:patient received follow-up on the date of discharge or within 30 days after discharge

•

en:patients who did not abstain from smoking prior to anesthesia on the day of surgery or procedure

•

en:patient did not achieve an improvement in visual acuity, from their preoperative level, within 90 days of surgery, reason not given

•

en:spoken language expression functional limitation, discharge status at discharge from therapy or to end reporting

•

en:patient with minor blunt head trauma did not have an appropriate indication(s) for a head ct

•

en:pneumococcal vaccination not administered prior to discharge, reason not specified

•

en:preoperative assessment documented

•

en:services performed by other qualified therapist in the hospice setting, each 15 minutes

•

en:patients in whom mrs score could not be obtained at 90 day follow-up

•

en:chlamydia, gonorrhea and syphilis screening results documented (report when results are present for all of the 3 screenings)

•

en:one high-risk medication ordered

•

en:i intend to report the optimizing patient exposure to ionizing radiation measures group

•

en:hepatitis c genotype testing was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given

•

en:final reports without documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique)

•

en:elective delivery or early induction performed

•

en:documentation of viral load less than 200 copies/ml

•

en:documentation of patient stroke following cea

•

en:amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis, reason not given

•

en:all quality actions for the applicable measures in the total knee replacement measures group have been performed for this patient

•

en:all quality actions for the applicable measures in the cardiovascular prevention measures group have been performed for this patient

•

en:advanced brain imaging (cta, ct, mra or mri) was ordered

•

en:no photodocumentation of cecal landmarks to establish a complete examination

•

en:any fasting or direct ldl-c laboratory test result = 190 mg/dl

•

en:patient did not have at least one medical visit in each 6 month period of the 24 month measurement period, with a minimum of 60 days between medical visits

•

en:documentation of patient survival and absence of stroke following cas

•

en:voice functional limitation, discharge status at discharge from therapy or to end reporting

•

en:spoken language expression functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:services performed by other counselor in the hospice setting, each 15 minutes

•

en:screening for hcv infection not received within the 12 month reporting period, reason not given

•

en:patient with an initial phq-9 score greater than nine who was not assessed for remission at twelve months (+/- 30 days)

•

en:patient was not referred to hospice care, reason not given

•

en:patient is not eligible (e.g., gynecologic or other pelvic malignancy documented, concurrent surgery involving bladder neoplasia or otherwise to treat a bladder specific problem, patient death from other causes, etc.)

•

en:patient discontinued from hemodialysis or peritoneal dialysis

•

en:pneumococcal screening performed and documentation of vaccination received prior to discharge

•

en:patients with documented shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure

•

en:other speech language pathology functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:no documentation of signed an opioid treatment agreement at least once during opioid therapy

•

en:intraoperative cystoscopy not performed to evaluate for lower tract injury

•

en:individual had a pdc of 0.8 or greater

•

en:incidental thyroid nodule < 1.0 cm noted in report

•

en:elective delivery or early induction not performed

•

en:door to puncture time of greater than 2 hours, no reason given

•

en:documented re-assessment for the appropriateness of filter removal within 3 months of placement

•

en:patients who abstained from smoking prior to anesthesia on the day of surgery or procedure

•

en:documentation of screening for uterine malignancy or those that had an ultrasound and/or endometrial sampling of any kind

•

en:other speech language pathology functional limitation, discharge status at discharge from therapy or to end reporting

•

en:patient starting antiviral treatment for hepatitis c during the measurement period

•

en:patient had one dose of meningococcal vaccine on or between the patient's 11th and 13th birthdays

•

en:patients with a normal neurological examination

•

en:patients who had a follow-up evaluation conducted at least every three months during opioid therapy

•

en:attention functional limitation, discharge status at discharge from therapy or to end reporting

•

en:national committee for quality assurance - level 3 medical home

•

en:evaluation for wheelchair requiring face to face visit with physician

•

en:ct scan of the paranasal sinuses not ordered at the time of diagnosis or received within 28 days after date of diagnosis

•

en:blood pressure has a systolic value of =140 and a diastolic value of = 90 or systolic value < 140 and diastolic value = 90 or systolic value = 140 and diastolic value < 90

•

en:at least two different high-risk medications not ordered

•

en:asthma well-controlled based on the act, c-act, acq, or ataq score and results documented

•

en:tobacco assessment or tobacco cessation intervention not performed, reason not given

•

en:radiation exposure indices, exposure time or number of fluorographic images not documented in final report for procedure using fluoroscopy, reason not given

•

en:i intend to report the multiple chronic conditions measures group

•

en:admission to medicare care choice model program (mccm)

•

en:patient did not sustain major viscus injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:at least two different high-risk medications ordered

•

en:prior thyroid disease diagnosis

•

en:patient who had a diagnosis of bipolar disorder or personality disorder, death, permanent nursing home resident or receiving hospice or palliative care any time during the measurement or assessment period

•

en:patient survey results not available

•

en:patient received follow-up within 7 days from discharge

•

en:shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure, not documented, reason not given

•

en:patient achieves final refraction (spherical equivalent) +/- 1.0 diopters of their planned refraction within 90 days of surgery

•

en:no unplanned hospital readmission within 30 days of principal procedure

•

en:no return to the operating room for a surgical procedure, for any reason, within 30 days of the principal operative procedure

•

en:history of receiving blood transfusions prior to 1992

•

en:final reports for ct or mri of the chest or neck or ultrasound of the neck with follow-up imaging not recommended

•

en:documentation of patient-specific risk assessment with a risk calculator based on multi-institutional clinical data, the specific risk calculator used, and communication of risk assessment from risk calculator with the patient or family not completed

•

en:patients who are not evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure including (e.g., history of dvt, pe, mi, arrhythmia and stroke, reason not given)

•

en:one ct scan or no ct scan of the paranasal sinuses ordered within 90 days after the date of diagnosis

•

en:patient receiving maintenance hemodialysis for greater than or equal to 90 days without a catheter as the mode of vascular access

•

en:patient not discharged to home by post-operative day #7

•

en:patient is not eligible (e.g., patient death during procedure, absent urethra or an otherwise inaccessible bladder)

•

en:patient did not have one dose of meningococcal vaccine on or between the patient's 11th and 13th birthdays

•

en:documentation of negative or managed positive tb screen with further evidence that tb is not active

•

en:follow-up recommendations not documented according to recommended guidelines for incidentally detected pulmonary nodules, reason not given

•

en:documentation of reason(s) for not screening for uterine malignancy (e.g., prior hysterectomy)

•

en:documentation of patient survival and absence of stroke following cea

•

en:documentation of medical reason(s) for not prescribing a beta-lactam antibiotic (e.g., allergy, intolerance to beta -lactam antibiotics)

•

en:ct studies performed not reported to a radiation dose index registry, reason not given

•

en:aspirin prescribed at discharge

•

en:patient received one-time screening for hcv infection

•

en:patient not receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills

•

en:patient was referred to hospice care

•

en:operative report does not identify the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant, reason not given

•

en:pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%

•

en:statin not prescribed for documented reasons (e.g., allergy, medical intolerance)

•

en:patient sustained major viscus injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:patient not offered assistance with end of life issues during the measurement period

•

en:patients who did not have a follow-up evaluation conducted at least every three months during opioid therapy

•

en:patient does not achieve final refraction (spherical equivalent) +/- 1.0 diopters of their planned refraction within 90 days of surgery, reason not given

•

en:i intend to report the acute otitis externa (aoe) measures group

•

en:follow-up recommendations documented according to recommended guidelines for incidentally detected pulmonary nodules (e.g., follow-up ct imaging studies needed or that no follow-up is needed) based at a minimum on nodule size and patient risk factors

•

en:final reports with documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique)

•

en:documentation of patient pain brought to a comfortable level within 48 hours from initial assessment

•

en:documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g., a solitary fibrous tumor in a person with a history of non-small cell carcinoma or other documented medical reasons)

•

en:total number of emergency department visits and inpatient hospitalizations less than two in the past 12 months

•

en:specimen site other than anatomic location of lung or is not classified as non small cell lung cancer

•

en:i intend to report the total knee replacement measures group

•

en:within the past 2 years, central dual-energy x-ray absorptiometry (dxa) not ordered and documented, no review of systems and no medication history or pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribed

•

en:previously diagnosed or have an active diagnosis of clinical ascvd

•

en:patient required a return to the operating room within 90 days of surgery

•

en:patient has been treated with a systemic or biologic medication for psoriasis for at least six months

•

en:patient did not receive follow-up on or within 7 days after discharge

•

en:patients who are not currently statin therapy users or did not receive an order (prescription) for statin therapy

•

en:order for first or second generation cephalosporin for antimicrobial prophylaxis was not documented, reason not given

•

en:aortic aneurysm 5.5 - 5.9 cm maximum diameter on centerline formatted ct or minor diameter on axial formatted ct

•

en:i intend to report the general surgery measures group

•

en:index date phq-9 score greater than 9 documented during the twelve month denominator identification period

•

en:incidental ct finding: liver lesion = 0.5 cm, cystic kidney lesion < 1.0 cm or adrenal lesion = 1.0 cm

•

en:final report documented that dicom format image data available to non-affiliated external healthcare facilities or entities on a secure, media free, reciprocally searchable basis with patient authorization for at least a 12-month period after the study

•

en:documentation of patient with one or more complications or mortality within 30 days

•

en:documentation of patient discharged to home no later than post operative day 2 following cas

•

en:documentation of medical reason(s) for not reporting pt category and a statement on thickness and ulceration and for pt1, mitotic rate (e.g., negative skin biopsies in a patient with a history of melanoma or other documented medical reasons)

•

en:ct studies performed reported to a radiation dose index registry with all necessary data elements

•

en:all quality actions for the applicable measures in the diabetic retinopathy measures group have been performed for this patient

•

en:blood pressure has a systolic value of < 140 and a diastolic value of < 90

•

en:documentation of medical reason(s) for not offering assistance with end of life issues (eg, patient in hospice and in terminal phase) during the measurement period

•

en:patient had at least one medical visit in each 6 month period of the 24 month measurement period, with a minimum of 60 days between medical visits

•

en:within the past 2 years, central dual-energy x-ray absorptiometry (dxa) not ordered or documented

•

en:documentation of patient discharged to home later than post-operative day 2 following cas

•

en:spoken language expression functional limitation, current status at therapy episode outset and at reporting intervals

•

en:services performed by qualified pharmacist in the hospice setting, each 15 minutes

•

en:psoriasis assessment tool documented meeting any one of the specified benchmarks (e.g., (pga; 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi))

•

en:pediatric patient with minor blunt head trauma not classified as low risk according to the pecarn prediction rules

•

en:patient whose mode of vascular access is a catheter at the time maintenance hemodialysis is initiated

•

en:patient starting antiviral treatmentfor hepatitis c during the measurement period

•

en:transesophageal doppler measurement of cardiac output (including probe placement, image acquisition, and interpretation per course of treatment) for monitoring purposes

•

en:patient did not undergo abdominal imaging and did not have a documented reason for not undergoing abdominal imaging in the reporting period

•

en:improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration performed for ed admitted patients

•

en:patients who had the prophylactic antibiotic completely infused prior to the inflation of the proximal tourniquet

•

en:documentation of reason(s) for not documenting a preoperative assessment (e.g., patient with a gynecologic or other pelvic malignancy noted at the time of surgery)

•

en:documentation of patient with one or more complications within 90 days

•

en:index date phq-score greater than 9 documented during the twelve month denominator identification period

•

en:i intend to report the diabetic retinopathy measures group

•

en:i intend to report the sinusitis measures group

•

en:memory functional limitation, current status at therapy episode outset and at reporting intervals

•

en:documentation that patient is a current tobacco user

•

en:patient did not sustain ureter injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:patient admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision

•

en:patient achieved an improvement in visual acuity, from their preoperative level, within 90 days of surgery

•

en:no surgical site infection

•

en:intraoperative cystoscopy performed to evaluate for lower tract injury

•

en:foot exam was not performed, reason not given

•

en:documentation that the patient is not on a statin medication

•

en:documentation of medical reason(s) that follow-up imaging is not indicated (e.g., patient has a known malignancy that can metastasize, other medical reason(s)

•

en:documentation of signed opioid treatment agreement at least once during opioid therapy

•

en:documentation of reason for not detecting adenoma(s) or other neoplasm. (e.g., neoplasm detected is only diagnosed as traditional serrated adenoma, sessile serrated polyp, or sessile serrated adenoma

•

en:documentation of post-surgical anatomy (e.g., right hemicolectomy, ileocecal resection, etc.)

•

en:documentation of patient death in the hospital following endovascular aaa repair

•

en:documentation of an order for anti-platelet agents or p2y12 antagonists

•

en:count of previous ct (any type of ct) and cardiac nuclear medicine (myocardial perfusion) studies documented in the 12-month period prior to the current study

•

en:chlamydia, gonorrhea, and syphilis not screened, due to documented reason (patient refusal is the only allowed exclusion)

•

en:patient transferred directly from anesthetizing location to pacu

•

en:patient identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method and received brief counseling

•

en:aspirin not prescribed at discharge

•

en:remission at six months not demonstrated by a six month (+/-30 days) phq-9 score of less than five; either phq-9 score was not assessed or is greater than or equal to five

•

en:national committee for quality assurance - level 2 medical home

•

en:unplanned rupture of the posterior capsule requiring vitrectomy during cataract surgery

•

en:services performed by chaplain in the hospice setting, each 15 minutes

•

en:remission at six months as demonstrated by a six month (+/-30 days) phq-9 score of less than five

•

en:patient with an initial phq-9 score greater than nine who achieves remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score of less than five

•

en:services performed by volunteer in the hospice setting, each 15 minutes

•

en:patient not treated with a beta-lactam antibiotic as definitive therapy, reason not given

•

en:p2y inhibitor prescribed at discharge

•

en:order for anti-platelet agents or p2y12 antagonists was not documented, reason not otherwise specified

•

en:patient received screening for hcv infection within the 12 month reporting period

•

en:door to puncture time of less than 2 hours

•

en:documentation of patient survival in the hospital following endovascular aaa repair

•

en:documentation of order for first or second generation cephalosporin for antimicrobial prophylaxis

•

en:documentation of medical reason(s) for not prescribing beta-blocker therapy (eg, allergy, intolerance, other medical reasons)

•

en:clinician treating major depressive disorder did not communicate to clinician treating comorbid condition for specified patient reason

•

en:a transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is used

•

en:unplanned return to the operating room for a surgical procedure, for any reason, within 30 days of the principal operative procedure

•

en:specimen site other than anatomic location of lung, is not classified as non small cell lung cancer or classified as nsclc-nos

•

en:documentation of viral load equal to or greater than 200 copies/ml or viral load not performed

•

en:non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation

•

en:history of injection drug use

•

en:imaging study named according to standardized nomenclature

•

en:more than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis, reason not given

•

en:prophylactic antibiotic not completely infused prior to the inflation of the proximal tourniquet, reason not given

•

en:no documentation of negative or managed positive tb screen

•

en:p2y inhibitor not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)

•

en:patients who have ever had a fasting or direct laboratory result of ldl-c = 190 mg/dl

•

en:patient survey score did not improve from baseline following treatment

•

en:final reports for ct or mri of the chest or neck or ultrasound of the neck with follow-up imaging recommended

•

en:all necessary data elements not included, reason not given

•

en:documentation of patient reason(s) for not prescribing beta-blocker therapy (eg, patient declined, other patient reasons)

•

en:documentation of patient death following cas

•

en:documentation of medical reason(s) for not screening for unhealthy alcohol use (e.g., limited life expectancy, other medical reasons)

•

en:documentation of a ct scan of the paranasal sinuses ordered at the time of diagnosis or received within 28 days after date of diagnosis

•

en:clinician documented reason patient was not able to complete 7 day follow-up from acute inpatient setting discharge (i.e patient death prior to follow-up visit, patient non-compliance for visit follow-up)

•

en:biologic immune response modifier prescribed

•

en:beta-blocker therapy not prescribed, reason not given

•

en:sinusitis caused by, or presumed to be caused by, bacterial infection

•

en:advanced brain imaging (cta, ct, mra or mri) was not ordered

•

en:screening performed and documentation that vaccination not indicated/patient refusal

•

en:final reports for abdominal imaging studies without a liver lesion < 0.5 cm, cystic kidney lesion < 1.0 cm or adrenal lesion < 1.0 cm noted

•

en:spoken language comprehension functional limitation, current status at therapy episode outset and at reporting intervals

•

en:one-time screening for hcv infection not received within 12 month reporting period and no documentation of prior screening for hcv infection, reason not given

•

en:spoken language comprehension functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:radiation exposure indices, exposure time or number of fluorographic images in final report for procedures using fluoroscopy, documented

•

en:preoperative assessment not documented, reason not given

•

en:patient with minor blunt head trauma had an appropriate indication(s) for a head ct

•

en:patient presented within 24 hours of a minor blunt head trauma with a gcs score of 15 and had a head ct ordered for trauma by an emergency care provider

•

en:patient not admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision

•

en:patient has not been treated with a systemic or biologic medication for psoriasis for at least six months

•

en:patient did not start or is not receiving antiviral treatment for hepatitis c during the measurement period

•

en:patient did not receive follow-up on the date of discharge or within 30 days after discharge

•

en:patients who have received or are receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills

•

en:primary non-small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation

•

en:mapcp demonstration - state provided services

•

en:hepatitis c quantitative rna testing was not documented as performed between 4-12 weeks after the initiation of antiviral treatment, reason not given

•

en:hepatitis c genotype testing documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c

•

en:final reports for ct or mri studies of the chest or neck or ultrasound of the neck without a thyroid nodule < 1.0 cm noted

•

en:documentation of patient without one or more complications within 90 days

•

en:documentation of patient reason(s) for not referring to hospice care (e.g., patient declined, other patient reasons)

•

en:documentation of medical reason(s) for not completely infusing the prophylactic antibiotic prior to the inflation of the proximal tourniquet (e.g., a tourniquet was not used)

•

en:documentation of end stage renal disease (esrd), dialysis, renal transplant or pregnancy

•

en:chlamydia, gonorrhea, and syphilis not screened, reason not given

•

en:all quality actions for the applicable measures in the aoe measures group have been performed for this patient

•

en:beta-blocker therapy prescribed or currently being taken

•

en:patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method

•

en:patient whose mode of vascular access is not a catheter at the time maintenance hemodialysis is initiated

•

en:asthma not well-controlled based on the act, c-act, acq, or ataq score, or specified asthma control tool not used, reason not given

•

en:pediatric patient with minor blunt head trauma classified as low risk according to the pecarn prediction rules

•

en:remission at twelve months not demonstrated by a twelve month (+/-30 days) phq-9 score of less than five; either phq-9 score was not assessed or is greater than or equal to 5

•

en:rna testing for hepatitis c was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given

•

en:influenza a (h1n1) and warfarin responsiveness testing

•

en:patients who were born in the years 1945-1965

•

en:documentation of patient reason(s) for not receiving one-time screening for hcv infection (e.g., patient declined, other patient reasons)

•

en:monitored anesthesia care (mac)

•

en:i intend to report the cardiovascular prevention measures group

•

en:intervention for presence of leak of endoluminal contents through an anastomosis required

•

en:improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration not performed for ed admitted patients

•

en:documentation of patient with pain not brought to a comfortable level within 48 hours from initial assessment

•

en:documentation of medical reason(s) for not including documentation that follow up imaging is not needed (e.g., patient has multiple endocrine neoplasia, patient has cervical lymphadenopathy, other medical reason(s))

•

en:currently a tobacco non-user

•

en:a transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is not used

•

en:antibiotic regimen prescribed

•

en:attention functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:attention functional limitation, current status at therapy episode outset and at reporting intervals

•

en:pathology report includes the pt category and a statement on thickness and ulceration and for pt1, mitotic rate

•

en:current cigarette smokers

•

en:documentation amoxicillin, with or without clavulanate, prescribed as a first line antibiotic at the time of diagnosis

•

en:total number of emergency department visits and inpatient hospitalizations equal to or greater than two in the past 12 months or patient not screened, reason not given

•

en:the highest fasting or direct ldl-c laboratory test result of 70-189 mg/dl in the measurement period or two years prior to the beginning of the measurement period

•

en:surgical site infection

•

en:post-partum screenings, evaluations and education performed

•

en:patient taking tamsulosin hydrochloride

•

en:patient receiving maintenance hemodialysis for greater than or equal to 90 days with a catheter as the mode of vascular access

•

en:patient not screened for unhealthy alcohol screening using a systematic screening method or patient did not receive brief counseling, reason not given

•

en:patient has a valid reason for a head ct for trauma being ordered, regardless of indications (ie, ventricular shunt, brain tumor, coagulopathy, including thrombocytopenia)

•

en:patient alive 3 months post procedure

•

en:patients without cardiac tamponade and/or pericardiocentesis occurring within 30 days

•

en:non small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation

•

en:motor speech functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:more than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis for documented reasons (eg, patients with complications, second ct obtained prior to surgery, other medical reasons)

•

en:more than one ct scan of the paranasal sinuses ordered or received within 90 days after diagnosis

•

en:functional outcome assessment documented, care plan not documented, documentation the patient is not eligible for a care plan

•

en:filter removed within 3 months of placement

•

en:elective surgical procedure

•

en:documentation that patient is a current non-tobacco user

•

en:documentation of patient stroke following cas

•

patient ▷

•

aspirine ▷

•

intervention chirurgicale à froid

◀

‹

362

en:chlamydia, gonorrhea, and syphilis not screened, due to documented reason (patient refusal is the only allowed exclusion)

•

en:pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%

•

en:motor speech functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:patients who had the prophylactic antibiotic completely infused prior to the inflation of the proximal tourniquet

•

en:primary non-small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation

•

en:patient with minor blunt head trauma had an appropriate indication(s) for a head ct

•

en:patient offered assistance with end of life issues during the measurement period

•

en:patients without cardiac tamponade and/or pericardiocentesis occurring within 30 days

•

en:no unplanned hospital readmission within 30 days of principal procedure

•

en:rna testing for hepatitis c was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given

•

en:antiretroviral therapy prescribed

•

en:aspirin not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)

•

intervention chirurgicale à froid

•

en:surgical site infection

•

en:documentation of medical reason(s) for not completely infusing the prophylactic antibiotic prior to the inflation of the proximal tourniquet (e.g., a tourniquet was not used)

•

en:i intend to report the sinusitis measures group

•

en:no surgical site infection

•

en:patient received one-time screening for hcv infection

•

en:documentation of patient pain brought to a comfortable level within 48 hours from initial assessment

•

en:patient discharge to home no later than post-operative day #7

•

en:i intend to report the diabetic retinopathy measures group

•

en:documentation of patient reason(s) for not referring to hospice care (e.g., patient declined, other patient reasons)

•

en:documentation that patient is a current non-tobacco user

•

en:door to puncture time of less than 2 hours

•

en:patient had at least one medical visit in each 6 month period of the 24 month measurement period, with a minimum of 60 days between medical visits

•

en:patients who are evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g. history of dvt, pe, mi, arrhythmia and stroke)

•

en:patient achieves final refraction (spherical equivalent) +/- 1.0 diopters of their planned refraction within 90 days of surgery

•

en:antibiotic regimen prescribed within10 days after onset of symptoms

•

en:services performed by other counselor in the hospice setting, each 15 minutes

•

en:within the past 2 years, central dual-energy x-ray absorptiometry (dxa) not ordered or documented

•

en:documentation of medical reason(s) for not offering assistance with end of life issues (eg, patient in hospice and in terminal phase) during the measurement period

•

en:a transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is used

•

en:statin not prescribed at discharge

•

en:no documentation of negative or managed positive tb screen

•

en:elective delivery or early induction performed

•

en:patient underwent abdominal imaging with ultrasound, contrast enhanced ct or contrast mri for hcc

•

en:specimen site other than anatomic cutaneous location

•

en:follow-up recommendations not documented according to recommended guidelines for incidentally detected pulmonary nodules, reason not given

•

en:i intend to report the total knee replacement measures group

•

en:documentation of post-surgical anatomy (e.g., right hemicolectomy, ileocecal resection, etc.)

•

en:patient achieved an improvement in visual acuity, from their preoperative level, within 90 days of surgery

•

en:patient did not achieve an improvement in visual acuity, from their preoperative level, within 90 days of surgery, reason not given

•

en:patient did not have one dose of meningococcal vaccine on or between the patient's 11th and 13th birthdays

•

en:patient transferred directly from anesthetizing location to pacu

•

en:pediatric patient with minor blunt head trauma classified as low risk according to the pecarn prediction rules

•

en:primary non-small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation

•

en:hepatitis c quantitative rna testing was not documented as performed between 4-12 weeks after the initiation of antiviral treatment, reason not given

•

en:services performed by other qualified therapist in the hospice setting, each 15 minutes

•

en:sinusitis caused by, or presumed to be caused by, bacterial infection

•

en:unplanned return to the operating room for a surgical procedure, for any reason, within 30 days of the principal operative procedure

•

en:influenza a (h1n1) and warfarin responsiveness testing

•

en:advanced brain imaging (cta, ct, mra or mri) was ordered

•

en:attention functional limitation, current status at therapy episode outset and at reporting intervals

•

en:at least two different high-risk medications ordered

•

en:documentation of system reason(s) for not prescribing beta-blocker therapy (eg, other reasons attributable to the health care system)

•

en:patient received follow-up within 7 days from discharge

•

en:index date phq-score greater than 9 documented during the twelve month denominator identification period

•

en:non small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation

•

en:no return to the operating room for a surgical procedure, for any reason, within 30 days of the principal operative procedure

•

en:patients with 90 day mrs score of 0 to 2

•

en:patient alive 3 months post procedure

•

en:patient not screened for unhealthy alcohol screening using a systematic screening method or patient did not receive brief counseling, reason not given

•

en:patient with minor blunt head trauma did not have an appropriate indication(s) for a head ct

•

en:voice functional limitation, discharge status at discharge from therapy or to end reporting

•

en:warfarin responsiveness testing by genetic technique using any method, any number of specimen(s)

•

en:services performed by dietary counselor in the hospice setting, each 15 minutes

•

en:patient with an initial phq-9 score greater than nine who was not assessed for remission at twelve months (+/- 30 days)

•

en:patient with an initial phq-9 score greater than nine who did not achieve remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score greater than or equal to five

•

en:final reports for ct or mri of the chest or neck or ultrasound of the neck with follow-up imaging recommended

•

en:patient identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method and received brief counseling

•

en:documented re-assessment for the appropriateness of filter removal within 3 months of placement

•

en:rna testing for hepatitis c documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c

•

en:patient received follow-up on the date of discharge or within 30 days after discharge

•

en:advanced brain imaging (cta, ct, mra or mri) was not ordered

•

en:blood pressure has a systolic value of =140 and a diastolic value of = 90 or systolic value < 140 and diastolic value = 90 or systolic value = 140 and diastolic value < 90

•

en:documentation of medical reason(s) that follow-up imaging is not indicated (e.g., patient has a known malignancy that can metastasize, other medical reason(s)

•

en:documentation of patient death following cas

•

en:documentation of system reason(s) for ordering an advanced brain imaging study (i.e., needed as part of a clinical trial; other clinician ordered the study)

•

en:documentation of viral load less than 200 copies/ml

•

en:patient whose mode of vascular access is a catheter at the time maintenance hemodialysis is initiated

•

en:imaging study named according to standardized nomenclature

•

en:patients who had a follow-up evaluation conducted at least every three months during opioid therapy

•

en:incidental ct finding: liver lesion = 0.5 cm, cystic kidney lesion < 1.0 cm or adrenal lesion = 1.0 cm

•

en:patients with clinical ascvd diagnosis

•

en:patient has been treated with a systemic or biologic medication for psoriasis for at least six months

•

en:patients who have ever had a fasting or direct laboratory result of ldl-c = 190 mg/dl

•

en:p2y inhibitor not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)

•

en:no unplanned rupture of the posterior capsule requiring vitrectomy during cataract surgery

•

en:no photodocumentation of cecal landmarks to establish a complete examination

•

en:national committee for quality assurance - level 3 medical home

•

en:national committee for quality assurance - level 1 medical home

•

en:screening performed and documentation that vaccination not indicated/patient refusal

•

en:services performed by care coordinator in the hospice setting, each 15 minutes

•

en:services performed by volunteer in the hospice setting, each 15 minutes

•

en:statin prescribed at discharge

•

en:voice functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:all quality actions for the applicable measures in the diabetic retinopathy measures group have been performed for this patient

•

en:documentation of reason(s) for not documenting a preoperative assessment (e.g., patient with a gynecologic or other pelvic malignancy noted at the time of surgery)

•

en:seen pre-operatively by anesthesiologist or proxy prior to the day of surgery

•

en:incidental thyroid nodule < 1.0 cm noted in report

•

en:memory functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:patient discontinued from hemodialysis or peritoneal dialysis

•

en:radiation exposure indices, exposure time or number of fluorographic images in final report for procedures using fluoroscopy, documented

•

en:post-partum screenings, evaluations and education not performed

•

en:services performed by chaplain in the hospice setting, each 15 minutes

•

en:spoken language expression functional limitation, current status at therapy episode outset and at reporting intervals

•

en:statin not prescribed for documented reasons (e.g., allergy, medical intolerance)

•

en:transesophageal doppler measurement of cardiac output (including probe placement, image acquisition, and interpretation per course of treatment) for monitoring purposes

•

en:prophylactic antibiotic not completely infused prior to the inflation of the proximal tourniquet, reason not given

•

en:spoken language expression functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:patient whose mode of vascular access is not a catheter at the time maintenance hemodialysis is initiated

•

en:documentation of patient discharged to home no later than post operative day 2 following cas

•

en:patient not screened for uterine malignancy, or those that have not had an ultrasound and/or endometrial sampling of any kind, reason not given

•

en:patient sustained ureter injury at the time of surgery or discovered subsequently up to 1 month post-surgery

•

en:p2y inhibitor not prescribed at discharge

•

en:elective surgical procedure

•

en:antibiotic regimen prescribed

•

en:antiretroviral thereapy not prescribed

•

en:aspirin prescribed at discharge

•

en:currently a tobacco non-user

•

en:i intend to report the acute otitis externa (aoe) measures group

•

en:documentation of reason(s) for not screening for uterine malignancy (e.g., prior hysterectomy)

•

en:intent for potential removal at time of placement

•

en:intraoperative cystoscopy performed to evaluate for lower tract injury

•

en:i intend to report the optimizing patient exposure to ionizing radiation measures group

•

en:motor speech functional limitation, discharge status, at discharge from therapy or to end reporting

•

en:non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation

•

en:patient did not receive follow-up on or within 7 days after discharge

•

en:patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method

•

en:final reports for abdominal imaging studies without a liver lesion < 0.5 cm, cystic kidney lesion < 1.0 cm or adrenal lesion < 1.0 cm noted

•

en:pathology report includes the pt category and a statement on thickness and ulceration and for pt1, mitotic rate

•

en:intervention for presence of leak of endoluminal contents through an anastomosis not required

•

en:memory functional limitation, current status at therapy episode outset and at reporting intervals

•

en:p2y inhibitor prescribed at discharge

•

en:patients who abstained from smoking prior to anesthesia on the day of surgery or procedure

•

en:patients who did not have a follow-up evaluation conducted at least every three months during opioid therapy

•

en:patient received screening for hcv infection within the 12 month reporting period

•

en:final reports for ct or mri of the chest or neck or ultrasound of the neck with follow-up imaging not recommended

•

en:patient with an initial phq-9 score greater than nine who achieves remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score of less than five

•

en:specimen site other than anatomic location of lung or is not classified as primary non-small cell lung cancer

•

en:hepatitis c quantitative rna testing documented as performed between 4-12 weeks after the initiation of antiviral treatment

•

en:mapcp demonstration - state provided services

•

en:elective delivery or early induction not performed

•

en:patients in whom mrs score could not be obtained at 90 day follow-up

•

en:documentation of active injection drug use

•

en:documentation of signed opioid treatment agreement at least once during opioid therapy

•

en:improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration not performed for ed admitted patients

•

en:major amputation or open surgical bypass required within 48 hours of the index endovascular lower extremity revascularization procedure

•

en:ct studies performed reported to a radiation dose index registry with all necessary data elements

•

en:patients who are not currently statin therapy users or did not receive an order (prescription) for statin therapy

•

en:patient survey score did not improve from baseline following treatment

•

en:patient was referred to hospice care

•

en:remission at twelve months not demonstrated by a twelve month (+/-30 days) phq-9 score of less than five; either phq-9 score was not assessed or is greater than or equal to 5

•

en:transfer of care during an anesthetic or to the intensive care unit

•

en:clinician treating major depressive disorder did not communicate to clinician treating comorbid condition for specified patient reason

•

en:patients who were born in the years 1945-1965

•

en:patient did not have at least one medical visit in each 6 month period of the 24 month measurement period, with a minimum of 60 days between medical visits

•

en:documentation of patient stroke following cas

•

en:documentation of viral load equal to or greater than 200 copies/ml or viral load not performed

•

en:dsm-ivtm criteria for major depressive disorder documented at the initial evaluation

•

en:final reports for abdominal imaging studies with follow-up imaging not recommended

•

en:more than one ct scan of the paranasal sinuses ordered or received within 90 days after diagnosis

•

en:patients with documented shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure

•

en:patient survey score improved from baseline following treatment

•

en:patient did not start or is not receiving antiviral treatment for hepatitis c during the measurement period

•

en:patient has not been treated with a systemic or biologic medication for psoriasis for at least six months

•

en:patient not offered assistance with end of life issues during the measurement period

•

en:screening for hcv infection not received within the 12 month reporting period, reason not given

•

en:specimen site other than anatomic location of lung or classified as nsclc-nos

•

en:spoken language comprehension functional limitation, discharge status, at discharge from therapy or to end reporting

•

en:documentation of order for first or second generation cephalosporin for antimicrobial prophylaxis

•

en:total number of emergency department visits and inpatient hospitalizations equal to or greater than two in the past 12 months or patient not screened, reason not given

•

en:all quality actions for the applicable measures in the multiple chronic conditions measures group have been performed for this patient

•

en:documentation of end stage renal disease (esrd), dialysis, renal transplant or pregnancy

•

en:patients who are currently statin therapy users or received an order (prescription) for statin therapy

•

en:all quality actions for the applicable measures in the sinusitis measures group have been performed for this patient

•

en:chlamydia, gonorrhea and syphilis screening results documented (report when results are present for all of the 3 screenings)

•

en:documentation that the patient is not on a statin medication

•

en:i intend to report the cardiovascular prevention measures group

•

en:documentation of patient death in the hospital following endovascular aaa repair

•

en:patient admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision

•

en:patient did not sustain ureter injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:patient had one dose of meningococcal vaccine on or between the patient's 11th and 13th birthdays

•

en:patient sustained bladder injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:pneumococcal vaccination not administered prior to discharge, reason not specified

•

en:specimen site other than anatomic location of lung, is not classified as non small cell lung cancer or classified as nsclc-nos

•

en:admission to medicare care choice model program (mccm)

•

en:patient did not require a return to the operating room within 90 days of surgery

•

en:patient not evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soaap-r) or patient not interviewed at least once during opioid therapy

•

en:major amputation or open surgical bypass not required within 48 hours of the index endovascular lower extremity revascularization procedure

•

en:other speech language pathology functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:patients prescribed opiates for longer than six weeks

•

en:patient did not undergo abdominal imaging and did not have a documented reason for not undergoing abdominal imaging in the reporting period

•

en:patient treated with a beta-lactam antibiotic as definitive therapy

•

en:patient not treated with a beta-lactam antibiotic as definitive therapy, reason not given

•

en:patient receiving maintenance hemodialysis for greater than or equal to 90 days with a catheter as the mode of vascular access

•

en:patient survey results not available

•

en:improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration performed for ed admitted patients

•

en:individual had a pdc of 0.8 or greater

•

en:documentation of patient with one or more complications within 90 days

•

en:one high-risk medication ordered

•

en:attention functional limitation, discharge status at discharge from therapy or to end reporting

•

en:ct scan of the paranasal sinuses not ordered at the time of diagnosis or received within 28 days after date of diagnosis

•

en:documentation of medical reason(s) for not screening for unhealthy alcohol use (e.g., limited life expectancy, other medical reasons)

•

en:hepatitis c genotype testing was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given

•

en:documentation of patient with one or more complications or mortality within 30 days

•

en:patients who did not abstain from smoking prior to anesthesia on the day of surgery or procedure

•

en:patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soaap-r) or patient interviewed at least once during opioid therapy

•

en:all quality actions for the applicable measures in the aoe measures group have been performed for this patient

•

en:documentation of patient survival and absence of stroke following cas

•

en:patient did not sustain major viscus injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:functional outcome assessment documented, care plan not documented, documentation the patient is not eligible for a care plan

•

en:hepatitis c genotype testing documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c

•

en:one-time screening for hcv infection not received within 12 month reporting period and no documentation of prior screening for hcv infection, reason not given

•

en:one high-risk medication not ordered

•

en:patients with cardiac tamponade and/or pericardiocentesis occurring within 30 days

•

en:patient did not receive follow-up on the date of discharge or within 30 days after discharge

•

en:the highest fasting or direct ldl-c laboratory test result of 70-189 mg/dl in the measurement period or two years prior to the beginning of the measurement period

•

en:patient starting antiviral treatmentfor hepatitis c during the measurement period

•

en:patient taking tamsulosin hydrochloride

•

en:patient was not referred to hospice care, reason not given

•

en:pediatric patient with minor blunt head trauma not classified as low risk according to the pecarn prediction rules

•

en:post-partum screenings, evaluations and education performed

•

en:prior thyroid disease diagnosis

•

en:services performed by qualified pharmacist in the hospice setting, each 15 minutes

•

en:documentation of screening for uterine malignancy or those that had an ultrasound and/or endometrial sampling of any kind

•

en:unplanned rupture of the posterior capsule requiring vitrectomy during cataract surgery

•

en:final reports for ct or mri studies of the chest or neck or ultrasound of the neck without a thyroid nodule < 1.0 cm noted

•

en:biologic immune response modifier prescribed

•

en:count of previous ct and cardiac nuclear medicine (myocardial perfusion) studies not documented in the 12-month period prior to the current study, reason not given

•

en:history of injection drug use

•

en:all necessary data elements not included, reason not given

•

en:all quality actions for the applicable measures in the total knee replacement measures group have been performed for this patient

•

en:a transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is not used

•

en:documentation of negative or managed positive tb screen with further evidence that tb is not active

•

en:documentation of patient reason(s) for not receiving one-time screening for hcv infection (e.g., patient declined, other patient reasons)

•

en:documentation of patient stroke following cea

•

en:count of previous ct (any type of ct) and cardiac nuclear medicine (myocardial perfusion) studies documented in the 12-month period prior to the current study

•

en:memory functional limitation, discharge status at discharge from therapy or to end reporting

•

en:patient not discharged to home by post-operative day #7

•

en:spoken language comprehension functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:tobacco assessment or tobacco cessation intervention not performed, reason not given

•

en:any fasting or direct ldl-c laboratory test result = 190 mg/dl

•

en:asthma not well-controlled based on the act, c-act, acq, or ataq score, or specified asthma control tool not used, reason not given

•

en:attention functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:monitored anesthesia care (mac)

•

en:blood pressure has a systolic value of < 140 and a diastolic value of < 90

•

en:documentation of patient without one or more complications within 90 days

•

en:documentation of at least two attempts to reach the patient to arrange a clinical re-assessment for the appropriateness of filter removal within 3 months of placement

•

en:documentation of patient death following cea

•

en:documentation of patient reason(s) for not receiving annual screening for hcv infection (e.g., patient declined, other patient reasons)

•

en:remission at six months as demonstrated by a six month (+/-30 days) phq-9 score of less than five

•

en:patient does not achieve final refraction (spherical equivalent) +/- 1.0 diopters of their planned refraction within 90 days of surgery, reason not given

•

en:pneumocystis jiroveci pneumonia prophylaxis prescribed wthin 3 months of low cd4+ cell count below 200 cells/mm3

•

en:preoperative assessment not documented, reason not given

•

en:remission at twelve months as demonstrated by a twelve month (+/-30 days) phq-9 score of less than 5

•

en:spoken language comprehension functional limitation, current status at therapy episode outset and at reporting intervals

•

en:aortic aneurysm 6.0 cm or greater maximum diameter on centerline formatted ct or minor diameter on axial formatted ct

•

en:intervention for presence of leak of endoluminal contents through an anastomosis required

•

en:remission at six months not demonstrated by a six month (+/-30 days) phq-9 score of less than five; either phq-9 score was not assessed or is greater than or equal to five

•

en:pcp prophylaxis was not prescribed within 3 months of low cd4+ cell count below 200 cells/mm3, reason not given

•

en:aortic aneurysm 5.5 - 5.9 cm maximum diameter on centerline formatted ct or minor diameter on axial formatted ct

•

en:aspirin not prescribed at discharge

•

en:documentation of patient without one or more complications and without mortality within 30 days

•

en:beta-blocker therapy not prescribed, reason not given

•

en:documentation that patient is a current tobacco user

•

en:mapcp demonstration - physician incentive pool

•

en:one ct scan or no ct scan of the paranasal sinuses ordered within 90 days after the date of diagnosis

•

en:pathology report does not include the pt category and a statement on thickness and ulceration and for pt1, mitotic rate

•

en:patients with 90 day mrs score greater than 2

•

en:documentation amoxicillin, with or without clavulanate, prescribed as a first line antibiotic at the time of diagnosis

•

en:photodocumentation of one or more cecal landmarks to establish a complete examination

•

en:preoperative assessment documented

•

en:voice functional limitation, current status at therapy episode outset and at reporting intervals

•

en:amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis, reason not given

•

en:antibiotic regimen not prescribed within 10 days after onset of symptoms

•

en:beta-blocker therapy prescribed or currently being taken

•

en:order for anti-platelet agents or p2y12 antagonists was not documented, reason not otherwise specified

•

en:filter removed within 3 months of placement

•

en:intraoperative cystoscopy not performed to evaluate for lower tract injury

•

en:i intend to report the multiple chronic conditions measures group

•

en:no documentation of signed an opioid treatment agreement at least once during opioid therapy

•

en:patient required a return to the operating room within 90 days of surgery

•

en:patient has a valid reason for a head ct for trauma being ordered, regardless of indications (ie, ventricular shunt, brain tumor, coagulopathy, including thrombocytopenia)

•

en:patient sustained major viscus injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:patient starting antiviral treatment for hepatitis c during the measurement period

•

en:national committee for quality assurance - level 2 medical home

•

en:patient did not sustained bladder injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:documentation of patient with pain not brought to a comfortable level within 48 hours from initial assessment

•

en:other speech language pathology functional limitation, discharge status at discharge from therapy or to end reporting

•

en:all quality actions for the applicable measures in the general surgery measures group have been performed for this patient

•

en:antibiotic regimen prescribed within 10 days after onset of symptoms for documented medical reason

•

en:ct studies performed not reported to a radiation dose index registry, reason not given

•

en:documentation of a ct scan of the paranasal sinuses ordered at the time of diagnosis or received within 28 days after date of diagnosis

•

en:documentation of patient survival and absence of stroke following cea

•

en:all quality actions for the applicable measures in the cardiovascular prevention measures group have been performed for this patient

•

en:dsm-iv-tr criteria for major depressive disorder not documented at the initial evaluation, reason not otherwise specified

•

en:foot exam was not performed, reason not given

•

en:individual did not have a pdc of 0.8 or greater

•

en:i intend to report the general surgery measures group

•

en:operative report identifies the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant

•

en:final reports for abdominal imaging studies with follow-up imaging recommended

•

en:order for first or second generation cephalosporin for antimicrobial prophylaxis was not documented, reason not given

•

en:documentation of medical reason(s) for not prescribing beta-blocker therapy (eg, allergy, intolerance, other medical reasons)

•

en:documentation of patient discharged to home later than post-operative day 2 following cas

•

en:documentation of patient survival in the hospital following endovascular aaa repair

•

en:documentation of planned hybrid or staged procedure

•

en:door to puncture time of greater than 2 hours, no reason given

•

en:history of receiving blood transfusions prior to 1992

•

en:imaging study not named according to standardized nomenclature, reason not given

•

en:mapcp demonstration - community health teams

•

en:other speech language pathology functional limitation, current status at therapy episode outset and at reporting intervals

•

en:patient not admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision

•

en:patient presented within 24 hours of a minor blunt head trauma with a gcs score of 15 and had a head ct ordered for trauma by an emergency care provider

•

en:pneumococcal screening performed and documentation of vaccination received prior to discharge

•

en:chlamydia, gonorrhea, and syphilis not screened, reason not given

•

en:current cigarette smokers

•

en:more than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis, reason not given

•

en:total number of emergency department visits and inpatient hospitalizations less than two in the past 12 months

•

en:evaluation for wheelchair requiring face to face visit with physician

•

en:all quality actions for the applicable measures in the optimizing patient exposure to ionizing radiation measures group have been performed for this patient

•

en:asthma well-controlled based on the act, c-act, acq, or ataq score and results documented

•

en:at least two different high-risk medications not ordered

•

en:documentation of an order for anti-platelet agents or p2y12 antagonists

•

en:documentation of medical reason(s) for not prescribing a beta-lactam antibiotic (e.g., allergy, intolerance to beta -lactam antibiotics)

•

en:documentation of patient reason(s) for not prescribing beta-blocker therapy (eg, patient declined, other patient reasons)

•

en:index date phq-9 score greater than 9 documented during the twelve month denominator identification period

•

en:symptomatic aaas that required urgent/emergent (non-elective) repair

•

en:patients with a normal neurological examination

•

en:patient is not eligible (e.g., patient death during procedure, absent urethra or an otherwise inaccessible bladder)

•

en:patient receiving maintenance hemodialysis for greater than or equal to 90 days without a catheter as the mode of vascular access

•

en:previously diagnosed or have an active diagnosis of clinical ascvd

•

en:radiation exposure indices, exposure time or number of fluorographic images not documented in final report for procedure using fluoroscopy, reason not given

•

en:specimen site other than anatomic location of lung or is not classified as non small cell lung cancer

•

en:spoken language expression functional limitation, discharge status at discharge from therapy or to end reporting

•

en:unplanned hospital readmission within 30 days of principal procedure

◀

• Mathieu Lafourcade • LIRMM (données libres en Creative Commons) •

• This page link : https://www.jeuxdemots.org/diko.php?gotermid=8128825 • caches: c1=32 c2=504 c3=407

....

+/-

♥

po

la

ti

le

as

ku

co

lo

to

ta

ta

xe

po

li

?!

!?

[Vider le cache]